| INTRODUCTION
Uterine diseases not related to pregnancy, mating or partus, can be associated with inflammation, infection or with other/unknown aetiological factors that influence the development of the disease, signs of illness, and possibilities for diagnosis, treatment options and outcome after selected choice of therapy. The uterine lesions can be divided by histopathological examination into abnormalities of endometrial growth and uterine infection and associated endometritis (inflammation of the endometrium) (Schlafer, 2012) . As the treatment options and prognosis for survival and full recovery differ largely, new methods and biomarkers that can be helpful in the clinical differentiation of patients with various diseases and for early diagnosis are needed. The most frequently encountered uterine diseases of nonpregnant bitches are cystic endometrial hyperplasia (CEH) and pyometra (Dow, 1959; Jitpean et al., 2012; Moxon, Whiteside, & England, 2016) . Neoplastic conditions are rare and congenital lesions relatively uncommon (Schlafer, 2012) .
Cystic endometrial hyperplasia (CEH) is generally defined as proliferation of endometrial glands, endometrial hyperplasia and formation of cysts and can be present with or without different types of fluid present in the uterus (Dow, 1959; Schlafer & Gifford, 2008) . The differentiation of diseases associated with uterine fluid but without infection, mucometra and hydrometra, is generally by visual inspection of the uterine fluid (or vaginal discharge), where a higher water content is defined as hydrometra, whereas when the appearance is more mucoid it is defined as mucometra. Hematometra, in which the fluid in the uterus has a hemorrhagic appearance, has been more rarely described in case reports and is clearly distinguishable by visual inspection (Troxel et al., 2002) . The incidence of CEH increases with age from <4% in bitches up to 3 years old to over 50% in bitches by 7 years of age (Moxon et al., 2016) . Although mild systemic inflammation may sometimes be detected in cases with CEH and mucometra/hydrometra, clinical signs of illness are generally absent or slight when there is no bacterial infection (Dow, 1959; Fransson et al., 2004) . Pyometra (defined as a chronic purulent endometritis post-oestrum, with or without polysystemic effects) affects in average one of five intact bitches before 10 years of age, and in some breeds over 50% of the bitches are diagnosed (Jitpean, Ström-Holst, et al. 2014 . Uterine neoplasia in dogs is relatively rare and mainly observed in middle-aged or older bitches, often because of the signs associated with uterine enlargement or concurrent other uterine disease such as pyometra or mucometra (McEntee, 2002; Patsikas et al., 2014) .
Endometritis is challenging to diagnose as it is seldom associated with uterine enlargement, and reduced fertility can be the only sign of illness (Mir et al., 2013; Schlafer & Gifford, 2008) . Mild endometritis is a feature that can be observed after mating, especially in bitches with CEH (England, Moxon, & Freeman, 2012) .
Differentiating diseases of the uterus resulting in uterine enlargement, with or without fluid in the uterus, is usually possible with diagnostic imaging techniques, foremost ultrasonographic examination which has the advantage compared to radiography in that it can detect minor amounts of fluid and uterine pathologies in a uterus that is otherwise of normal size. So far there are no clinically available biomarkers for diagnosis of specific uterine diseases in dogs.
| UTERINE DISEASE DEVELOPMENT
Cystic endometrial hyperplasia and pyometra may develop acutely or have a more gradual progression during several oestrus cycles, and they occur more frequently with increasing age (Dow, 1959; Moxon et al., 2016) . The degree of systemic illness may vary from mild CEH, mucometra or hydrometra with no or few clinical signs to a critical case of pyometra that requires intensive care and immediate intervention to prevent death. Early diagnosis of uterine infection is a prerequisite for early start of treatment and for promoting survival because of potentially life-threatening systemic effects, sepsis and serious complications that may develop. The pathogenesis is not yet completely understood, but according to the predominant theory, repeated influence of progesterone plays an important role in the pathogenesis of CEH and pyometra, inducing a gradually more pronounced development of CEH with subsequent accumulation of fluid in the uterus, uterine inflammation and susceptibility to opportunistic bacterial infection (pyometra) (Dow, 1959) . This concept of a disease entity, the "CEH-pyometra complex," with pyometra as the most severe end-stage, has more recently been questioned as the clinical signs mainly depend on whether these is inflammation present or not (De Bosschere, Ducatelle, Vermeirsch, Van Den Broeck, & Coryn, 2001; Dow, 1959) . Exogenous hormone treatment has been linked with increased risk for developing CEH and pyometra, further supporting the importance of hormones in the pathogenesis (Chen, Lee, & Wright, 2006; Niskanen & Thrusfield, 1998; Teunissen, 1952) . However, it is also possible to induce the disease process by bacteria, degeneration within tissues with CEH or by other intrauterine factors such as when performing uterine biopsies (Krekeler et al., 2013) .
As for proliferative lesions, pseudoplacentational endometrial hyperplasia (PEH) is characterized by highly organized remodelling of the endometrial lining more similar to placentation sites in normal pregnancy and endometrial cysts and that differs from what is observed in CEH (Schlafer & Gifford, 2008; Schlafer, 2012) . Other more rarely occurring uterine disorders such as endometrial polyps and neoplasia can also be found in the uterus and be associated with inflammatory uterine changes or not, and as for CEH and PEH, the development is not yet fully understood (Schlafer & Gifford, 2008) . The prospect of spontaneous neoplasia in canine patients as a natural disease model for human cancer is promising as a win-win for improving knowledge on genetics, diagnostics, possible biomarkers and treatments (Davis & Ostrander, 2014) .
| THE IMPORTANCE OF DETECTING NOVEL MOLECULAR MARKERS
Early diagnosis is central for increasing the likelihood of complete recovery and fertility in cases with less severe pathological changes of the uterus. Improved methods for detecting uterine disease caused by bacterial infection are imperative for optimal treatment and for minimizing unnecessary antimicrobial use in cases where bacterial infection is absent (Wedley et al., 2017) . Identifying suitable biomarkers for early diagnosis of uterine disorders and their differentiation is thus highly warranted. Novel advances in the field of genetics and genetic test development might enable selection breeding dogs that are more resistant to uterine diseases in breeds with high risk of these diseases (Jitpean et al., 2012) . Blocking hormonal action or vaccinating against bacterial virulence factors may be future non-surgical preventive alternatives, and molecular markers may be useful for identification of important hormonal factors and more susceptible individuals (Krekeler et al., 2012; Teunissen, 1952) .
Molecular markers are measured to obtain information about systemic effects as detected in for example in blood or urine, or more localized processes in the uterine tissue by cytological smears or biopsies (Fransson et al., 2004; Mir et al., 2013) . This is important especially in the uterine diseases that can be associated with life-threatening infection and sepsis, in which laboratory variables contribute with valuable information for determining the severity | 39 HAGMAN of illness and organ dysfunctions (Wheaton et al., 1989) . Moreover, genetic studies for identifying individuals prone to develop different diseases are conducted and certain genetic marker tests applied in breeding programs to encourage breeding animals of the healthiest individuals which are less affected by inherited disorders. Breed is an important risk factor for uterine disease development. Some breeds have been shown to be more prone to developing pyometra and at an earlier age than other breeds, indicating that there may be genetic factors to consider (Jitpean et al., 2012) . Similarly, breed differences have recently been shown also for the development of CEH (Moxon et al., 2016) . Pregnancy is considered to slightly reduce the risk for pyometra, at least in some breeds, which points to breed differences also regarding protective factors (Niskanen & Thrusfield, 1998; Hagman et al., 2011 ). Yet, pregnancy is not completely protective, and CEH was reported to be a common feature in breeding bitches despite the possible protective effects of regular pregnancies (Moxon et al., 2016) . 
| MOLECULAR MARKERS IN PYOMETRA

Systemic inflammatory response syndrome (SIRS) is present in over 50%
of bitches suffering from pyometra (Fransson et al., 2007) . Higher blood concentrations of endotoxin have been related to poor outcome (death) in dogs with the disease but so far there is no rapid, reliable and costeffective method for endotoxin analysis (Okano, Tagawa, & Takase, 1998) .
In pyometra cases diagnosed with SIRS, circulating concentrations of C-reactive protein (CRP), Prostaglandin 15-ketodihydro-PGF 2α metabolite (PGM), Serum amyloid A and other inflammatory mediators are increased (Fransson et al., 2007; Hagman et al., 2006; Karlsson et al., 2016) . Severe complications associated with pyometra include sepsis, septic shock, peritonitis, disseminated bacterial infection organ dysfunctions and death (Conti-Patara et al., 2012; Marretta, Matthiesen, & Nichols, 1989; Heiene et al., 2007) . The generalized disease, often present in pyometra, affects several organ systems leading to alteration of many variables investigated (Åsheim, 1963; Capiau, De Schepper, & Van Der Stock, 1987; Conti-Patara et al., 2012; Hagman et al., 2006; Maddens et al., 2011) .
Although pyometra is a life-threatening illness, the prognosis is favourable in most cases and with a reported mortality rate of 10% including euthanasia (Jitpean, Ström-Holst, et al., 2014). The ability of clinical and laboratory variables to predict prognosis or the presence of complications has recently been evaluated (Jitpean, Ström-Holst, et al., 2014) . Leucopenia was deemed the most important predictive factor because it was associated with an 18-fold increased risk of peritonitis and a 3.5-fold increased risk of prolonged post-operative hospitalization (Jitpean, Ström-Holst, et al., 2014) . Moreover, peritonitis and/or prolonged post-operative hospitalization were associated with findings of abnormal rectal temperature, depression and pale mucous membranes. Findings from clinical examination and laboratory testing may thus be useful for predicting prognosis in pyometra, but additional prospective studies are required for confirmation.
Measuring inflammatory variables during recovery may be helpful for early detection of complications and systemic inflammation.
Surgical trauma may induce additional inflammation the day after surgery, which subsequently reduces during recovery until concentrations are normalized (Dabrowski et al., 2015) . If concentrations of acute phase proteins CRP, Serum amyloid A and Haptoglobin and other inflammatory markers do not decrease, or perhaps increase, a systemic inflammation because of complications can be suspected (Dabrowski, Kostro, Lisiecka, Szczubiał, & Krakowski, 2009; Dabrowski et al., 2009 ). Molecular markers that detect other systemic abnormalities induced by the disease and for monitoring organ functions will also be helpful to assess during recovery (Fransson et al., 2004; Hagman, 2014; Verstegen, Dhaliwal, & Verstegen-Onclin, 2008) .
| MOLECULAR MARKERS IN THE DIFFERENTIATION OF UTERINE DISEASES
There are no molecular markers available for clinical practice that can differentiate between various uterine diseases unless in cases where a systemic response is induced. There are several markers for systemic inflammation and various organ function tests that are helpful for optimal management of the affected dog, but these are not specific for the uterine disorders (Fransson et al., 2004) . Mucometra, hydrometra, hematometra and pyometra are associated with uterine enlargement and the presence of fluid in the uterine lumen, with or without CEH.
In pyometra, there is a bacterial infection, that is, a risk of endotoxemia and subsequent SIRS. When selecting the optimal treatment it is important to be able to differentiate pyometra from other uterine diseases because pyometra is a considered a potential medical emergency, and for this some clinical signs and laboratory variables may be helpful. The general condition of the bitch is more often depressed in pyometra, and clinical signs such as lethargy and gastro-intestinal disturbances more frequently present (Fransson et al., 2004; Hagman et al., 2006) . If the bitch shows more than three clinical signs, pyometra is also more likely. Moreover, the inflammatory response induced is more distinct in pyometra, which is apparent by the results of analyses of laboratory variables and inflammatory mediators (Veiga et al., 2017) . Percentage band neutrophils, CRP and PGM may be useful as single or combined markers for predicting pyometra versus mucometra (Fransson et al., 2004; Hagman et al., 2006) . Leucocyte differential counts are generally performed, and analysis of CRP is becoming increasingly used as automated canine-specific methods for routine clinical use have been developed (Hillström, Hagman, Tvedten, & Kjelgaard-Hansen, 2014) . Novel methods or markers for diagnosis, detectable in vaginal discharge, could be of interest to explore for diagnostic purposes (Burfeind et al., 2012) .
It is challenging to diagnose subclinical endometritis or other disorders unless uterine enlargement or fluid in the uterine lumen is detectable (Fontaine et al., 2009; Mir et al., 2013) . Vaginal cytology is normal in most of these cases, and generally no apparent clinical signs of illness are seen in the bitch (Mir et al., 2013; Verstegen et al., 2008) . If the uterine disease induces systemic inflammation, this may be detected by laboratory investigations of CRP or other inflammatory markers (Dabrowski et al., 2015; Karlsson et al., 2016; Hagman, Rönnberg and Pejler, 2009) . Uterine cytology or histology of transcervically obtained samples of biopsies is often necessary for diagnosis of milder uterine conditions (Chotimanukul & Sirivaidyapong, 2011; Christensen et al., 2012; Fontaine et al., 2009; Groppetti, Pecile, Arrighi, Di Giancamillo, & Cremonesi, 2001; Günzel-Apel, Wilke, Aupperle, & Schoon, 2001; Mir et al., 2013; Watts, Wright, Lee, & Whithear, 1997) .
| IDENTIFICATION OF NOVEL MOLECULAR MARKERS
Recently the global gene expression was explored in uterine tissues from dogs with CEH, mucometra and pyometra (Bukowska et al., 2014; Hagman, Rönnberg, & Pejler, 2009; Voorwald et al., 2015) . One of the studies detected 29 specific genes that are activated in pyometra (Voorwald et al., 2015) . Many of these genes are associated with chemokines, cytokines, inflammatory cell extravasation, antibacterial action, the complement system and innate immune responses (Bukowska et al., 2014; Hagman et al., 2009; Voorwald et al., 2015) .
Another trait of pyometra is increased activation and production of proteases, particularly matrix metalloproteases and also toll-like receptors (Chu Py, Salamonsen, Lee, & Wright, 2002; Hagman et al., 2009; Silva et al., 2012; Voorwald et al., 2015) . Products of activated genes specific for different uterine diseases could have potential as molecular markers for diagnostic tests in challenging cases to improve the methods for predicting outcome or as new therapeutic targets (Hagman, 2014; Karlsson et al., 2015) . Of the more interesting genes and their respective products to explore further are the secretory leucocyte peptidase inhibitor (SLPI), prostaglandin synthases (PTGS2/COX2), matrix metalloproteinases (MMPs), calcium-binding proteins of the S100 family (S100A12, S100A8 and S100A9), interleukins (IL) foremost IL-8/ CXCL8 and IL-6 as these were the most highly activated genes in pyometra (Voorwald et al., 2015) . It is possible to measure many of these products in dogs, although tests are not yet available for routine analysis in clinical practice (Haas, Kaup, & Neumann, 2016; Hagman et al., 2006; Heilmann et al., 2016; Karlsson et al., 2012) . The possibility to develop tests for analysis of many more gene products in the uterine discharge or other body fluids is likely to be more investigated in the future. In a recent report, it was also noted that the uterine gene expression in pyometra differed in bitches that had earlier been treated with exogenous progestogen compounds (Voorwald et al., 2015) . The effect of exogenous hormone treatments and possibilities to influence (activate or deactivate) genes of uterus deserves further studying. Whether the cervix is open or closed in pyometra also influences the uterine gene expression and this is worth investigating further as the diagnosis can be more challenging when there is no vaginal discharge and the illness is often more severe in these cases (Voorwald et al., 2015) .
| CONCLUSIONS
Molecular markers helpful for an early diagnosis of uterine diseases are needed. Early diagnosis and subsequent early therapeutic intervention improve chances of recovery and restored fertility, and prevents progression to more severe disease stages and development of potentially life-threatening complications. Suitable biomarkers should be sensitive and specific, and preferably useful for diagnosis, prognostication and estimation of the response to treatment. Activation of genes and the resulting products may be measured, and could be useful as markers for diagnostic or prognostic purposes if tests are developed. Research applying the latest technologies is warranted to obtain more knowledge about the genetic background, aetiology, pathogenesis and clinical findings of the different uterine diseases, and will be valuable for detecting and evaluating novel molecular markers.
CONFLICT OF INTEREST
The author has declared no conflict of interests.
